Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015

1
Polycystic Kidney Disease Global Clinical Trials
Review, H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Polycystic Kidney Disease Global Clinical Trials
  Review, H2, 2015 provides an overview of
  Polycystic Kidney Disease clinical trials
  scenario. This report provides top line data
  relating to the clinical trials on Polycystic
  Kidney Disease. Report includes an overview of
  trial numbers and their average enrollment in top
  countries conducted across the globe. The report
  offers coverage of disease clinical trials by
  region, country (G7 E7) , phase, trial status,
  end points status and sponsor type. Report also
  provides prominent drugs for in-progress trials
  (based on number of ongoing trials) .
• Scope
• The report provides a snapshot of the global
  clinical trials landscape
• Report provides top level data related to the
  clinical trials by Region, Country (G7 E7) ,
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• The report provides all the unaccomplished trials
  (Terminated, Suspended and Withdrawn) with reason
  for unaccomplishment
• The Report provides enrollment trends for the
  past five years
• Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/polycy
  stic-kidney-disease-global-clinical-trials-review-
  h2-2015-market

3


Table of Content
Table of Contents 2 List of Tables 4 List of
Figures 5 Introduction 6 Polycystic Kidney
Disease 6 Report Guidance 6 Clinical Trials by
Region 7 Clinical Trials and Average Enrollment
by Country 8 Top Five Countries Contributing to
Clinical Trials in Asia-Pacific 10 Top Five
Countries Contributing to Clinical Trials in
Europe 11 Top Countries Contributing to Clinical
Trials in North America 12 Top Countries
Contributing to Clinical Trials in Middle East
and Africa 13 Top Five Countries Contributing to
Clinical Trials in Central and South America
14 Clinical Trials by G7 Countries Proportion of
Polycystic Kidney Disease to Genito Urinary
System And Sex Hormones Clinical Trials
15 Clinical Trials by Phase in G7 Countries
16 Clinical Trials in G7 Countries by Trial
Status 17 Clinical Trials by E7 Countries
Proportion of Polycystic Kidney Disease to Genito
Urinary System And Sex Hormones Clinical Trials
18 Clinical Trials by Phase in E7 Countries
19 Clinical Trials in E7 Countries by Trial
Status 20 Clinical Trials by Phase 21
4


Table of Content
In Progress Trials by Phase 22 Clinical Trials by
Trial Status 23 Clinical Trials by End Point
Status 24 Unaccomplished Trials of Polycystic
Kidney Disease 25 Subjects Recruited Over a
Period of Time 27 Clinical Trials by Sponsor Type
28 Prominent Sponsors 29 Top Companies
Participating in Polycystic Kidney Disease
Therapeutics Clinical Trials 30 Prominent Drugs
31 Clinical Trial Profiles 32 Clinical Trial
Overview of Top Companies 32 Otsuka Holdings Co.,
Ltd. 32 Clinical Trial Overview of Otsuka
Holdings Co., Ltd. 32 Pfizer Inc. 34 Clinical
Trial Overview of Pfizer Inc. 34 Ipsen S.A.
35 Clinical Trial Overview of Ipsen S.A.
35 Novartis AG 36 Clinical Trial Overview of
Novartis AG 36 Enquire At http//www.researchbe
am.com/polycystic-kidney-disease-global-clinical-t
rials-review-h2-2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/polycystic-kidney-dise
ase-global-clinical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com